Paper2575602
Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Maton PN and 2 others. Gastroenterol Clin North Am, 1989. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Papers, record 2575602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2575602
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastric Acid | Major topic |
| Histamine H2 Antagonists | Major topic |
| Zollinger-Ellison Syndrome | Major topic |
| Cimetidine | |
| Famotidine | |
| Humans | |
| Nizatidine | |
| Omeprazole | |
| Parasympatholytics | |
| Ranitidine | |
| Thiazoles |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11281187 | Primary calcified gastrinoma of the liver. | Dig Dis Sci | 2001 | https://conductscience.org/library/papers/11281187 | PubMed |
| 8799683 | Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion. | Drugs | 1996 | https://conductscience.org/library/papers/8799683 | PubMed |
| 8425437 | Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome. | Dig Dis Sci | 1993 | https://conductscience.org/library/papers/8425437 | PubMed |
| 8395751 | Use of octreotide acetate for control of symptoms in patients with islet cell tumors. | World J Surg | 1993 | https://conductscience.org/library/papers/8395751 | PubMed |
| 8362529 | Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. | World J Surg | 1993 | https://conductscience.org/library/papers/8362529 | PubMed |
| 8323088 | Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach. | Ann Intern Med | 1993 | https://conductscience.org/library/papers/8323088 | PubMed |
| 8103251 | Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I. | World J Surg | 1993 | https://conductscience.org/library/papers/8103251 | PubMed |
| 7916560 | Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. | Ann Surg | 1994 | https://conductscience.org/library/papers/7916560 | PubMed |
| 1671617 | Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome. | World J Surg | 1991 | https://conductscience.org/library/papers/1671617 | PubMed |
| 1531004 | Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. | Ann Surg | 1992 | https://conductscience.org/library/papers/1531004 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2575602
GET https://conductscience.org/api/papers/v1/2575602/authors